Jane Street Group, LLC Brainstorm Cell Therapeutics Inc. Put Options Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2021

Nov 16, 2021
SELL
$3.14 - $4.09 $24,806 - $32,311
-7,900 Reduced 39.9%
11,900 $39,000
Q2 2021

Aug 16, 2021
SELL
$3.01 - $4.01 $92,407 - $123,107
-30,700 Reduced 60.79%
19,800 $75,000
Q1 2021

May 18, 2021
SELL
$3.46 - $7.88 $41,866 - $95,348
-12,100 Reduced 19.33%
50,500 $193,000
Q4 2020

Feb 17, 2021
BUY
$3.99 - $17.73 $209,874 - $932,598
52,600 Added 526.0%
62,600 $283,000
Q3 2020

Nov 17, 2020
BUY
$11.19 - $16.92 $111,900 - $169,200
10,000 New
10,000 $169,000

Others Institutions Holding BCLI

# of Institutions
38
Shares Held
10.6M
Call Options Held
160K
Put Options Held
30.5K
View Full List

About BRAINSTORM CELL THERAPEUTICS INC.

BCLI Quotes by TradingView
  • Ticker BCLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,486,200
  • Market Cap $73.7M
  • Description
  • Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...
More about BCLI
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email